SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

BioLine Rx Q1 EPS $(0.040) Beats $(0.660) Estimate

BioLine Rx (NASDAQ:BLRX) reported quarterly losses of $(0.040) per share which beat the analyst consensus estimate of $(0.660) by 93.94 percent. This is a 20 percent increase over losses of $(0.050) per share from the

Benzinga · 05/20/2020 11:09

BioLine Rx (NASDAQ:BLRX) reported quarterly losses of $(0.040) per share which beat the analyst consensus estimate of $(0.660) by 93.94 percent. This is a 20 percent increase over losses of $(0.050) per share from the same period last year.